Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs

Nucleic Acids Research

Volumn 29, Issue 19, 2001, Pages 3965-3974

  Sazani, Peter ^a   Kang, Shin Hong ^a   Maier, Martin A ^b   Wei, Changfu ^b   Dillman, Jennifer ^a   Summerton, James ^c   Manoharan, Muthiah ^b   Kole, Ryszard ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b ISIS PHARMACEUTICALS   (United States)

^c Gene Tools   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2' O METHOXYETHYL PHOSPHOROTHIOATE; 2' O METHYL PHOSPHOROTHIOATE; ANION; ANTISENSE OLIGONUCLEOTIDE; CATION; GREEN FLUORESCENT PROTEIN; HOMEODOMAIN PROTEIN; LYSINE; MESSENGER RNA; MORPHOLINE DERIVATIVE; MORPHOLINO; OLIGOMER; PEPTIDE NUCLEIC ACID; PHOSPHOROTHIOIC ACID DERIVATIVE; RNA PRECURSOR; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; NUCLEIC ACID HYBRIDIZATION; PRIORITY JOURNAL; RNA SPLICING; VALIDATION PROCESS;

EID: 0035477551     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/29.19.3965     Document Type: Article

References (38)

1. Progress in antisense technology: The end of the beginning
2. Antisense therapeutics
3. Antisense comes of age
4. Vitravene-another piece in the mosaic
5. Keeping the biotechnology of antisense in context
6. Nonantisense effects of antisense oligonucleotides
7. Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines
8. 2′-carbohydrate modifications in antisense oligonucleotide therapy: Importance of conformation, configuration and conjugation
9. Synthesis of deoxynucleoside methylphosphonates via phosphonamidite approach
10. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide
11. Modified oligodeoxynucleotides as antisense therapeutics
12. Novel chemistry
13. Antisense effects in the cell nucleus: Modification of splicing
14. Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis
15. Morpholino antisense oligomers: The case for an RNase H-independent structural type
16. Thalassemia syndromes
17. Up-regulation of luciferase gene expression with antisense oligonucleotides: Implications and applications in functional assay development
18. A rapid method for recombination and site-specific mutagenesis by placing homologous ends on DNA using polymerase chain reaction
19. Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides
20. Uncharged stereoregular nucleic acid analogs: 2. Morpholino nucleoside oligomers with carbamate internucleoside linkages
21. Solid-phase synthesis of peptide nucleic acids
22. Improvements in automated PNA synthesis using Boc/Z monomers
23. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides
24. A simple method for delivering morpholino antisense oligos into the cytoplasm of cells
25. Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake
26. Modification of alternative splicing pathways as a potential approach to chemotherapy
27. Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients
28. The delivery of antisense therapeutics
29. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides
30. Altered mRNA splicing and inhibition of human E-selectin expression by an antisense oligonucleotide in human umbilical vein endothelial cells
31. Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing
32. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides
33. Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNAs by antisense oligonucleotides
34. Modification of alternative splicing of pre-mRNA by antisense oligonucleotides
35. Protein transduction: Unrestricted delivery into all cells?
36. Translocation properties of novel cell penetrating transportan and penetratin analogues
37. Trojan peptides: The penetratin system for intracellular delivery
38. Cell-penetrating peptides